Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of noninfected rats

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 6, 2005, Pages 2356-2361

  Marchand, Sandrine ^a,b   Dahyot, Claire ^b   Lamarche, Isabelle ^a   Mimoz, Olivier ^a,b   Couet, William ^a,b,c  

^a Faculte de Medicine et de Pharmacie   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c Pole Biologie Sante   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CILASTATIN PLUS IMIPENEM; IMIPENEM; ISOFLURANE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; INTERSTITIAL FLUID; LUNG; LUNG FLUID; MALE; MICRODIALYSIS; MUSCLE; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; EXTRACELLULAR FLUID; IMIPENEM; LUNG; MALE; MICRODIALYSIS; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 19544380049     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.6.2356-2361.2005     Document Type: Article

References (32)

1. Acar, J. F. 1985. Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience. Rev. Infect. Dis. 7:S513-S517.
2. Avram, M. J., T. C. Krejcie, C. U. Niemann, C. Enders-Klein, C. A. Shanks, and T. K. Henthorn. 2000. Isoflurane alters the recirculatory pharmacokinetics of physiologic markers. Anesthesiology 92:1757-1768.
3. Berkeley, A. S., K. S. Freedman, J. C. Hirsch, and W. J. Ledger. 1986. Randomized, comparative trial of imipenem/cilastatin and moxalactam in the treatment of serious obstetric and gynaecological infections. Surg. Gynecol. Obstet. 162:204-208.
4. Bouw, M. R., and M. Hammarlund-Udenaes. 1998. Methodological aspects of the use of calibrator in in vivo microdialysis-further development of retrodialysis method. Pharm. Res. 15:1673-1679.
5. Brunner, M., T. Pernerstorfer, B. X. Mayer, H. G. Eichler, and M. Müller. 2000. Surgery and intensive care procedures affect the target site distribution of piperacillin. Crit. Care Med. 28:1754-1759.
6. Chastre, J., and J. L. Trouillet. 2000. Problem pathogens (Pseudomonas aeruginoa and Acinetobacter). Semin. Respir. Infect. 15:261-263.
7. Dalla Costa, T., A. Nolting, A. Kovar, and H. Derendorf. 1998. Determination of free interstitial concentrations of piperacillin-tazobactam combinations by microdialysis. J. Antimicrob. Chemother. 42:769-778.
8. Davis, B., and T. Morris. 1993. Physiological parameters in labotary animals and humans. Pharm. Res. 10:1093-1095.
9. Deguchi, Y., T. Terasaki, H. Yamada, and A. Tsuji. 1992. An application of microdialysis to drug tissue distribution study: in vivo evidence for free-ligand hypothesis and tissue binding of β-lactam antibiotics in interstitial fluids. J. Pharmacobio-Dyn. 15:79-89.
10. de la Peña, A., P. Liu, and H. Derendorf. 2000. Microdialysis in peripheral tissues. Adv. Drug Deliv. Rev. 45:189-216.
11. de la Peña, A., T. Dalla Costa, J. D. Talton, E. Rehak, J. Gross, U. Thyroff-Friesinger, A. I. Webb, M. Müller, and H. Derendorf. 2001. Penetration of cefaclor into the interstitial space fluid of skeletal muscle and lung tissue in rats. Pharm. Res. 18:1310-1314.
12. Dupuis, A., W. Couet, J. Paquereau, S. Debarre, A. Portron, C. Jamois, and S. Bouquet. 2001. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of imipenem in healthy rats. Antimicrob. Agents Chemother. 45:1682-1687.
13. Dupuis, A., A. Limosin, J. Paquereau, O. Mimoz, W. Couet, and S. Bouquet. 2001. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of imipenem in rats with acute renal failure. Antimicrob. Agents Chemother. 45:3607-3609.
14. Freddo, R., and T. Dalla Costa. 2002. Determination of norfloxacin free interstitial levels in skeletal muscle by microdialysis. J. Pharm. Sci. 91:2433-2440.
15. Huang, Y., P. Ji, A. Inano, Z. Yang, G. S. Giebink, and R. J. Sawchuk. 2001. Microdialysis studies of the middle ear distribution kinetics of amoxicillin in the awake chinchilla. J. Pharm. Sci. 90:2088-2098.
16. Jardin, F., G. Delorme, A. Hardy, B. Auvert, A. Beauchet, and J. L. Bourdarias. 1990. Reevaluation of hemodynamic consequences of positive pressure ventilation: emphasis on cyclic right ventricular afterloading mechanical lung inflation. Anesthesiology 72:966-970.
17. Joukhadar, C., N. Klien, B. X. Mayer, N. Kreischitz, G. Delle-Karth, P. Palkovits, G. Heinz, and M. Müller. 2002. Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis. Crit. Care Med. 30:1478-1482.
18. Kager, L., and C. E. Nord. 1985. Imipenem/cilastatin in the treatment of intraabdominal infections: a review of worldwide experience. Rev. Infect. Dis. 7:S518-S521.
19. Kovar, A., T. Dalla Costa, and H. Derendorf. 1997. Comparison of plasma and free tissue levels of ceftriaxone in rats by microdialysis. J. Pharm. Sci. 86:52-56.
20. Limosin, A., A. Dupuis, I. Lamarche, O. Mimoz, J. Paquereau, and W. Couet. 2004. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of imipenem in rats with experimental hypovolaemia or endotoxaemia. J. Antimicrob. Chemother. 54:187-192.
21. Liu, P., M. Muller, and H. Derendorf. 2002. Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. Int. J. Antimicrob. Agents 19:285-290.
22. Liu, P., M. Muller, M. Grant, A. I. Webb, B. Obermann, and H. Derendorf. 2002. Interstitial tissue concentrations of cefpodoxime. J. Antimicrob. Chemother. 20:19-22.
23. Morgan, B. C., W. E. Martin, T. F. Hornbein, et al. 1966. Hemodynamic effect of intermittent positive pressure ventilation. Anesthesiology 27:584-590.
24. Mouton, J. W, D. J. Touzw, A. M. Horrevorts, and A. A. Vinks. 2000. Comparative pharmacokinetics of the carbapanems: clinical implications. Clin. Pharmacokinet. 39:185-201.
25. Nolting, A., T. Dalla Costa, R. Vistelle, K. H. Rand, and H. Derendorf. 1996. Determination of free concentrations of piperacillin by microdialysis. J. Pharm. Sci. 85:369-372.
26. Rowland, M., and T. M. Tozer. 1989. Small volume of distribution, p. 438-450. In Clinical pharmacokinetics: concepts and applications, 2nd ed. Lea and Febiger, Philadelphia, Pa.
27. Seyde, W. C., and D. E. Longnecker. 1984. Anesthetic influences on regional hemodynamics in normal and haemorrhaged rats. Anesthesiology 61:686-698.
28. Tegeder, I., A. Schmidtko, L. Bräutigam, A. Kirchbaum, G. Geisslinger, and J. Lötsch. 2002. Tissue distribution of imipenem in critically ill patients. Clin. Pharmacol. Ther. 71:325-333.
29. Tomaselli, F., P. Dittrich, A. Maier, M. Woltsche, V. Matzi, J. Pinter, S. Nuhsbaumer, H. Pinter, J. Smolle, and F. M. Smolle-Jüttner. 2003. Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis. Br. J. Clin. Pharmacol. 55:620-624.
30. Tomaselli, F., A. Maier, V. Matzi, F. M. Smolle-Juttner, and P. Dittrich. 2004. Penetration of meropenem into pneumonic human lung tissue as measured by in vivo microdialysis. Antimicrob. Agents Chemother. 48:2228-2232.
31. Tunblad, K., E. N. Jonsson, and M. Hammarlund-Udenaes. 2003. Morphine blood-brain barrier transport is influenced by probenecid co-administration. Pharm. Res. 20:618-623.
32. Wade, J. C., H. C. Standiford, G. L. Drusano, D. E. Johnson, M. R. Moory, C. I. Bustamante, J. H. Joshi, C. deJongh, and S. C. Schimpff. 1985. Potential imipenem as single-agent empiric antibiotic therapy of febrile and neutropenic patients with cancer. Am. J. Med. 78:62-72.